TY - JOUR T1 - Brain-computer interface (BCI) evaluation in people with amyotrophic lateral sclerosis. JF - Amyotroph Lateral Scler Frontotemporal Degener Y1 - 2014 A1 - McCane, Lynn M A1 - Sellers, Eric W A1 - Dennis J. McFarland A1 - Mak, Joseph N A1 - Carmack, C Steve A1 - Zeitlin, Debra A1 - Jonathan Wolpaw A1 - Theresa M Vaughan KW - Adult KW - Aged KW - Amyotrophic Lateral Sclerosis KW - Biofeedback, Psychology KW - brain-computer interfaces KW - Communication Disorders KW - Electroencephalography KW - Event-Related Potentials, P300 KW - Female KW - Humans KW - Male KW - Middle Aged KW - Online Systems KW - Photic Stimulation KW - Psychomotor Performance KW - Reaction Time AB - Brain-computer interfaces (BCIs) might restore communication to people severely disabled by amyotrophic lateral sclerosis (ALS) or other disorders. We sought to: 1) define a protocol for determining whether a person with ALS can use a visual P300-based BCI; 2) determine what proportion of this population can use the BCI; and 3) identify factors affecting BCI performance. Twenty-five individuals with ALS completed an evaluation protocol using a standard 6 × 6 matrix and parameters selected by stepwise linear discrimination. With an 8-channel EEG montage, the subjects fell into two groups in BCI accuracy (chance accuracy 3%). Seventeen averaged 92 (± 3)% (range 71-100%), which is adequate for communication (G70 group). Eight averaged 12 (± 6)% (range 0-36%), inadequate for communication (L40 subject group). Performance did not correlate with disability: 11/17 (65%) of G70 subjects were severely disabled (i.e. ALSFRS-R < 5). All L40 subjects had visual impairments (e.g. nystagmus, diplopia, ptosis). P300 was larger and more anterior in G70 subjects. A 16-channel montage did not significantly improve accuracy. In conclusion, most people severely disabled by ALS could use a visual P300-based BCI for communication. In those who could not, visual impairment was the principal obstacle. For these individuals, auditory P300-based BCIs might be effective. VL - 15 UR - http://www.ncbi.nlm.nih.gov/pubmed/24555843 IS - 3-4 ER -